Acquired 43,897 shares
of Common Stock
(Direct)
Date: 2026-03-08 |
Code: A
| equity_swap_involved: 0 | shares_owned_after: 112,635.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
F1: Represents a grant of restricted stock units (RSUs) that are exempt from Section 16b-3 and are subject to vesting in three equal annual installments from the date of grant. RSUs represent a contingent right to receive one share of DexCom, Inc. Common Stock.
F2: Included in this number are 112,635 unvested RSUs, 43,897 of which were granted on March 8, 2026 and shall vest through March 8, 2029, and 68,738 of which were granted on May 22, 2025 and shall vest through May 22, 2029.
🔍 Coleman Jon (Executive)
Company: DEXCOM INC (DXCM)
Report Date: 2026-03-08
Transaction Summary:
Detailed Transactions and Holdings:
Date: 2026-03-08 | Code: A | equity_swap_involved: 0 | shares_owned_after: 112,635.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes: